Last update :
19/09/2022
References   References 4652  
Type : Manufacturer

Research teams :
Authors :
Title : Nivolumab (Opdivo®) - Summary of Product Characteristics
Reference : Bristol Myers Squibb Pharmaceuticals 2022

Level of Evidence : 
Manufacturer's stability data
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
InjectionNivolumab Anticancer drug
Stability in solutions Glass Sodium chloride 0,9% 1 >> 10 mg/ml 2-8°C Protect from light
30 Day
Stability in solutions Glass Sodium chloride 0,9% 1 >> 10 mg/ml 25°C Light
24 Hour
Stability in solutions Glass Glucose 5% 1 >> 10 mg/ml 2-8°C Protect from light
7 Day
Stability in solutions Glass Glucose 5% 1 >> 10 mg/ml 25°C Light
8 Hour
Stability in solutions Glass None 10 mg/ml 25°C Light
48 Hour
Stability in solutions Polyvinyl chloride Sodium chloride 0,9% 1 >> 10 mg/ml 2-8°C Protect from light
30 Day
Stability in solutions Polyvinyl chloride Sodium chloride 0,9% 1 >> 10 mg/ml 25°C Light
24 Hour
Stability in solutions Polyvinyl chloride Glucose 5% 1 >> 10 mg/ml 2-8°C Protect from light
7 Day
Stability in solutions Polyvinyl chloride Glucose 5% 1 >> 10 mg/ml 25°C Light
8 Hour
Stability in solutions Polyolefine Sodium chloride 0,9% 1 >> 10 mg/ml 2-8°C Protect from light
30 Day
Stability in solutions Polyolefine Sodium chloride 0,9% 1 >> 10 mg/ml 25°C Light
24 Hour
Stability in solutions Polyolefine Glucose 5% 1 >> 10 mg/ml 2-8°C Protect from light
7 Day
Stability in solutions Polyolefine Glucose 5% 1 >> 10 mg/ml 25°C Light
8 Hour

  Mentions Légales